PedAM
Pediatric Disease Annotations & Medicines
| Disease | breast cancer |
| Symptom | C0016382|flushes |
| Sentences | 6 |
| PubMedID- 23346316 | As a major recommendation with good and consistent scientific evidence (level a), selective serotonin reuptake inhibitors (ssris) and serotonin-norepinephrine reuptake inhibitors (snris) have both been shown to be safe and to reduce the severity of hot flushes in patients with breast cancer, although caution must be used when using these agents in conjunction with tamoxifen. |
| PubMedID- 20450413 | Modeling hot flushes and quality of life in breast cancer survivors. |
| PubMedID- 20347238 | Objective: to review and summarise current evidence on the efficacy and safety of herbal medicinal products for the relief of hot flushes in women with previous breast cancer. |
| PubMedID- 24313623 | Hot flushes in women with breast cancer: state of the art and future perspectives. |
| PubMedID- 24423018 | Management of hot flushes in breast cancer survivors: comparison between stellate ganglion block and pregabalin. |
| PubMedID- 26498637 | The pharmacological and hormonal therapy of hot flushes in breast cancer survivors. |
Page: 1